Evidence map›Paper›PMID 35474180›Full record

ArticleStroke and vascular neurology2022

Functional status at 30 and 90 days after mild ischaemic stroke.

Hannah Gardener, Leo A Romano, Eric E Smith, Iszet Campo-Bustillo, Yosef Khan, Sofie Tai, Nikesha Riley, Ralph L Sacco, Pooja Khatri, Heather M Alger and 10 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Stroke and vascular neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02072681 (Mild and Rapidly Improving Stroke Study), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02072681 completednot on this map

Mild and Rapidly Improving Stroke Study

Typeobservational_patient_registrySponsorUniversity of MiamiRan2015 to 2021Enrolled2,175ConditionsIschemic Stroke
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. The association between social networks and functional recovery after stroke.International journal of stroke : official journal of the International Stroke Society · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Editorial: minor stroke is not minor.Stroke and vascular neurology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

Hannah GardenerNeurology, University of Miami Miller School of Medicine, Miami, Florida, USA hgardener@med.miami.edu.ORCID http://orcid.org/0000-0003-1416-632X
Leo A RomanoNeurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Eric E SmithHotchkiss Brain Institute, Univ Calgary, Calgary, Alberta, Canada.ORCID http://orcid.org/0000-0003-3956-1668
Iszet Campo-BustilloNeurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Yosef KhanAmerican Heart Association, American Heart Association, Dallas, Texas, USA.
Sofie TaiAmerican Heart Association, American Heart Association, Dallas, Texas, USA.
Nikesha RileyAmerican Heart Association, American Heart Association, Dallas, Texas, USA.
Ralph L SaccoNeurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Pooja KhatriNeurology and Rehabilitation Medicine, Univ Cincinnati, Cincinnati, Ohio, USA.
Heather M AlgerAmerican Heart Association, American Heart Association, Dallas, Texas, USA.
Brian Mac GroryNeurology, Duke University School of Medicine, Durham, North Carolina, USA.
Deepak GulatiNeurology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID http://orcid.org/0000-0003-3374-5992
Navdeep S SanghaNeurology, Los Angeles Medical Center, Los Angeles, California, USA.
Karin E OldsNeurology, St Luke's Hospital, Kansas City, Missouri, USA.
Curtis G BeneschNeurology, University of Rochester, Rochester, New York, USA.
Adam G KellyNeurology, University of Rochester, Rochester, New York, USA.
Scott S BrehautStroke Center, Faxton St. Luke's Healthcare, Utica, New York, USA.
Amit C KansaraNeurology, Providence St Vincent Medical Center, Portland, Oregon, USA.
Lee H SchwammNeurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jose G RomanoNeurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
University of Miami · USAmerican Heart Association · USUniversity of Rochester · USDuke University · USFaxton St. Luke's Healthcare · USLos Angeles Medical Center · USMassachusetts General Hospital · USProvidence St. Vincent Medical Center · USSt. Luke's Hospital · USThe Ohio State University Wexner Medical Center · USUniversity of Cincinnati · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectiveThis study compares the global disability status of patients who had a mild ischaemic stroke at 30 and 90 days poststroke, as measured by the modified Rankin Scale (mRS), and identifies predictors of change in disability status between 30 and 90 days.

methodsThe study population included 1339 patients who had a ischaemic stroke enrolled in the Mild and Rapidly Improving Stroke Study with National Institutes of Health (NIH) stroke score 0-5 and mRS measurements at 30 and 90 days. Outcomes were (1) Improvement defined as having mRS >1 at 30 days and mRS 0-1 at 90 days OR mRS >2 at 30 days and mRS 0-2 at 90 days and (2) Worsening defined as an increase of ≥2 points or a worsening from mRS of 1 at 30 days to 2 at 90 days. Demographic and clinical characteristics at hospital arrival were abstracted from medical records, and regression models were used to identify predictors of functional improvement and decline from 30 to 90 days post-stroke. Significant predictors were mutually adjusted in multivariable models that also included age and stroke severity.

resultsFifty-seven per cent of study participants had no change in mRS value from 30 to 90 days. Overall, there was moderate agreement in mRS between the two time points (weighted kappa=0.59 (95% CI 0.56 to 0.62)). However, worsening on the mRS was observed in 7.54% of the study population from 30 to 90 days, and 17.33% improved. Participants of older age (per year OR 1.02, 95% CI 1.00 to 1.03), greater stroke severity (per NIH Stroke Scale (NIHSS) point at admission OR 1.17, 95% CI 1.03 to 1.34), and those with no alteplase treatment (OR 1.72, 95% CI 1.11 to 2.69) were more likely to show functional decline after mutual adjustment. DISCUSSION: A quarter of all mild ischaemic stroke participants exhibited functional changes between 30 and 90 days, suggesting that the 30-day outcome may insufficiently represent long-term recovery in mild stroke and longer follow-up may be clinically necessary. TRIAL REGISTRATION NUMBER: NCT02072681.

Indexed as

Risk FactorsStroke

Identifiers

PMID35474180
PMCPMC9614160
OpenAlexW4224990402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.